CYP2C19 Genotyping

Optimizing your cardiovascular medication plan requires a deep understanding of your biological makeup, and precise molecular insights bring profound peace of mind and enhanced therapeutic safety. Housed within our Molecular Diagnostics division, our CYP2C19 Genotyping testing utilizes targeted genomic sequencing to analyze exactly how your body metabolizes crucial antiplatelet medications like clopidogrel. Rather than delivering a final standalone clinical diagnosis, this expansive pharmacogenetic data empowers your cardiologist with the critical molecular clarity required to select targeted therapies and provide highly personalized medical guidance. Renowned among top diagnostic labs in Dubai and the UAE, DNA Labs UAE ensures strict patient confidentiality and consistently rapid, precise results. Empower your specialized cardiovascular journey: discover our CYP2C19 genotyping testing in the UAE below to book your test, schedule a gentle home collection, or speak with our experts.